- Home
- ALZN vs ATPC Comparison
ALZN vs ATPC Comparison
Compare ALZN & ATPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- ATPC
- Stock Information
- Founded
- ALZN 2016
- ATPC 2016
- Country
- ALZN United States
- ATPC Malaysia
- Employees
- ALZN N/A
- ATPC N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- ATPC Medical/Nursing Services
- Sector
- ALZN Health Care
- ATPC Health Care
- Exchange
- ALZN Nasdaq
- ATPC Nasdaq
- Market Cap
- ALZN 6.9M
- ATPC 7.8M
- IPO Year
- ALZN 2021
- ATPC N/A
- Fundamental
- Price
- ALZN $1.66
- ATPC $1.85
- Analyst Decision
- ALZN
- ATPC
- Analyst Count
- ALZN 0
- ATPC 0
- Target Price
- ALZN N/A
- ATPC N/A
- AVG Volume (30 Days)
- ALZN 271.9K
- ATPC 4.6M
- Earning Date
- ALZN 09-11-2024
- ATPC 08-14-2024
- Dividend Yield
- ALZN N/A
- ATPC N/A
- EPS Growth
- ALZN N/A
- ATPC N/A
- EPS
- ALZN N/A
- ATPC N/A
- Revenue
- ALZN N/A
- ATPC $1,378,067.00
- Revenue This Year
- ALZN N/A
- ATPC N/A
- Revenue Next Year
- ALZN N/A
- ATPC N/A
- P/E Ratio
- ALZN N/A
- ATPC N/A
- Revenue Growth
- ALZN N/A
- ATPC N/A
- 52 Week Low
- ALZN $1.40
- ATPC $1.36
- 52 Week High
- ALZN $34.50
- ATPC $220.00
- Technical
- Relative Strength Index (RSI)
- ALZN 39.08
- ATPC 43.94
- Support Level
- ALZN $1.55
- ATPC $1.72
- Resistance Level
- ALZN $1.68
- ATPC $2.04
- Average True Range (ATR)
- ALZN 0.14
- ATPC 0.15
- MACD
- ALZN 0.05
- ATPC 0.01
- Stochastic Oscillator
- ALZN 60.47
- ATPC 4.47
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About ATPC Agape ATP Corporation
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company are to supply high-quality health and wellness products, including a supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in a body. Its product portfolio includes ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, AGN-Vege Fruit Fiber and Others.